Drew Ranieri
Stock Analyst at Morgan Stanley
(1.46)
# 2,394
Out of 4,413 analysts
148
Total ratings
39.33%
Success rate
-12.82%
Average return
Main Sectors:
19 Stocks
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| STVN Stevanato Group | Maintains: Equal-Weight | $30 | $28.04 | +6.99% | 15 | Apr 22, 2024 | |
| NPCE NeuroPace | Maintains: Equal-Weight | $9 → $13 | $12.99 | +0.08% | 11 | Mar 6, 2024 | |
| SIBN SI-BONE | Maintains: Overweight | $25 → $26 | $14.26 | +82.33% | 12 | Feb 27, 2024 | |
| SYK Stryker | Maintains: Equal-Weight | $300 → $320 | $336.50 | -4.90% | 6 | Dec 4, 2023 | |
| OM Outset Medical | Maintains: Equal-Weight | $5 → $5.5 | $2.53 | +117.39% | 10 | Dec 4, 2023 | |
| ORGO Organogenesis Holdings | Maintains: Equal-Weight | $3 → $3.5 | $2.35 | +48.94% | 3 | Nov 14, 2023 | |
| GMED Globus Medical | Maintains: Equal-Weight | $60 → $53 | $49.79 | +6.45% | 9 | Nov 14, 2023 | |
| ATEC Alphatec Holdings | Maintains: Overweight | $23 → $17 | $12.62 | +34.71% | 7 | Nov 14, 2023 | |
| AGTI Agiliti | Maintains: Underweight | $10 → $8 | $10.15 | -21.18% | 10 | Nov 14, 2023 | |
| TMCI Treace Medical Concepts | Maintains: Overweight | $30 → $14 | $10.37 | +35.00% | 9 | Nov 13, 2023 | |
| NVST Envista Holdings | Maintains: Overweight | $42 → $38 | $19.68 | +93.09% | 9 | Nov 2, 2023 | |
| IART Integra LifeSciences Holdings | Maintains: Underweight | $44 → $37 | $29.17 | +26.84% | 8 | Oct 26, 2023 | |
| HAE Haemonetics | Maintains: Equal-Weight | $88 → $96 | $91.95 | +4.40% | 9 | May 12, 2023 | |
| AVNS Avanos Medical | Maintains: Underweight | $28 → $26 | $18.08 | +43.81% | 8 | May 4, 2023 | |
| BDX Becton, Dickinson and Company | Maintains: Overweight | $290 → $295 | $234.60 | +25.75% | 2 | Feb 3, 2023 | |
| TFX Teleflex | Maintains: Equal-Weight | $236 → $280 | $208.75 | +34.13% | 5 | Jan 6, 2023 | |
| BVS Bioventus | Maintains: Overweight | $11 → $5 | $3.96 | +26.26% | 6 | Nov 10, 2022 | |
| BAX Baxter International | Maintains: Overweight | $72 → $70 | $40.37 | +73.40% | 4 | Oct 11, 2022 | |
| ISRG Intuitive Surgical | Maintains: Equal-Weight | $325 → $300 | $370.62 | -19.05% | 5 | Apr 25, 2022 |
Stevanato Group
Apr 22, 2024
Maintains: Equal-Weight
Price Target: $30
Current: $28.04
Upside: +6.99%
NeuroPace
Mar 6, 2024
Maintains: Equal-Weight
Price Target: $9 → $13
Current: $12.99
Upside: +0.08%
SI-BONE
Feb 27, 2024
Maintains: Overweight
Price Target: $25 → $26
Current: $14.26
Upside: +82.33%
Stryker
Dec 4, 2023
Maintains: Equal-Weight
Price Target: $300 → $320
Current: $336.50
Upside: -4.90%
Outset Medical
Dec 4, 2023
Maintains: Equal-Weight
Price Target: $5 → $5.5
Current: $2.53
Upside: +117.39%
Organogenesis Holdings
Nov 14, 2023
Maintains: Equal-Weight
Price Target: $3 → $3.5
Current: $2.35
Upside: +48.94%
Globus Medical
Nov 14, 2023
Maintains: Equal-Weight
Price Target: $60 → $53
Current: $49.79
Upside: +6.45%
Alphatec Holdings
Nov 14, 2023
Maintains: Overweight
Price Target: $23 → $17
Current: $12.62
Upside: +34.71%
Agiliti
Nov 14, 2023
Maintains: Underweight
Price Target: $10 → $8
Current: $10.15
Upside: -21.18%
Treace Medical Concepts
Nov 13, 2023
Maintains: Overweight
Price Target: $30 → $14
Current: $10.37
Upside: +35.00%
Envista Holdings
Nov 2, 2023
Maintains: Overweight
Price Target: $42 → $38
Current: $19.68
Upside: +93.09%
Integra LifeSciences Holdings
Oct 26, 2023
Maintains: Underweight
Price Target: $44 → $37
Current: $29.17
Upside: +26.84%
Haemonetics
May 12, 2023
Maintains: Equal-Weight
Price Target: $88 → $96
Current: $91.95
Upside: +4.40%
Avanos Medical
May 4, 2023
Maintains: Underweight
Price Target: $28 → $26
Current: $18.08
Upside: +43.81%
Becton, Dickinson and Company
Feb 3, 2023
Maintains: Overweight
Price Target: $290 → $295
Current: $234.60
Upside: +25.75%
Teleflex
Jan 6, 2023
Maintains: Equal-Weight
Price Target: $236 → $280
Current: $208.75
Upside: +34.13%
Bioventus
Nov 10, 2022
Maintains: Overweight
Price Target: $11 → $5
Current: $3.96
Upside: +26.26%
Baxter International
Oct 11, 2022
Maintains: Overweight
Price Target: $72 → $70
Current: $40.37
Upside: +73.40%
Intuitive Surgical
Apr 25, 2022
Maintains: Equal-Weight
Price Target: $325 → $300
Current: $370.62
Upside: -19.05%